您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2025, Vol. 63 ›› Issue (1): 35-42.doi: 10.6040/j.issn.1671-7554.0.2024.0570

• 临床研究 • 上一篇    

circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响

张洁1,张芳芳1,王靖楠2,李泽宇1,宋颖1,李娜1   

  1. 1.河南省新乡医学院病理学系, 河南 新乡 453003;2.河南省新乡医学院三全学院, 河南 新乡 453003
  • 发布日期:2025-02-20
  • 通讯作者: 李娜. E-mail:yaoyao-lina@163.com
  • 基金资助:
    河南省教育厅高校重点科研项目(24A310010);新乡医学院大创计划项目(202410472052)

Expression of circ_0000144 in breast cancer and its effect on the proliferation, migration and invasion ability of breast cancer cells

ZHANG Jie1, ZHANG Fangfang1, WANG Jingnan2, LI Zeyu1, SONG Ying1, LI Na1   

  1. 1. Department of Pathology, Xinxiang Medical University, Xinxiang 453003, Henan, China;
    2. Sanquan College of Xinxiang Medical University, Xinxiang 453003, Henan, China
  • Published:2025-02-20

摘要: 目的 探究circ_0000144在乳腺癌组织中的表达及其对乳腺癌细胞增殖、凋亡、迁移和侵袭能力的影响。 方法 通过实时荧光定量PCR(quantitative real-time polymerase chain reaction, RT-qPCR)实验检测49例乳腺癌及配对癌旁正常乳腺组织标本中的circ_0000144表达水平,并分析circ_0000144的表达水平与乳腺癌患者临床病理特征的关系;以正常乳腺上皮细胞MCF-10A为对照,RT-qPCR法检测乳腺癌细胞系(T47D、MCF-7、MDA-MB-231)中circ_0000144表达;以MCF-7细胞为研究对象,将转染si-circ_0000144组设为实验组(si-circ_0000144组),将转染si-NC组设为生理盐水对照组(si-NC组),同时设置空白对照组(Control组),细胞不进行任何转染操作,用常规培养基进行培养,通过CCK-8、克隆形成实验、流式细胞术、划痕实验、Transwell实验检测乳腺癌细胞中细胞增殖、迁移和侵袭的能力,Western blotting法检测相关蛋白CyclinD1、p21、Bax、Bcl-2、E-cadherin和N-cadherin表达。 结果 与癌旁正常组织比较,乳腺癌组织中circ_0000144表达显著升高(P<0.001),且与TNM分期和淋巴结转移呈密切正相关(P=0.003,P=0.007);与正常乳腺上皮细胞MCF-10A比较,乳腺癌细胞系中circ_0000144表达上调(P<0.001);与Control组或si-NC组比较,si-circ_0000144组增殖、迁移和侵袭能力降低(P<0.001),凋亡率升高(P均<0.001),CyclinD1、Bcl-2和N-cadherin蛋白表达水平降低(P均<0.001),而p21、Bax和E-cadherin蛋白表达水平升高(P均<0.001)。 结论 circ_0000144在乳腺癌组织及细胞系中呈高表达,下调circ_0000144可阻碍乳腺癌细胞增殖、迁移和侵袭,而促进其凋亡,circ_0000144有望成为治疗乳腺癌的分子靶点。

关键词: 乳腺癌, circ_0000144, 增殖, 凋亡, 迁移, 侵袭

Abstract: Objective To explore the expression of circ_0000144 in breast cancer tissues and its effect on the proliferation, apoptosis, migration and invasion abilities of breast cancer cells. Methods Quantitative real-time polymerase chain reaction(RT-qPCR)experiments were performed to detect the expression level of circ_0000144 in 49 breast cancer tissues and paired paracancerous normal breast tissue specimens and to analyze the relationship between the expression level of circ_0000144 and the clinicopathological characteristics of breast cancer patients. Normal breast epithelial cells MCF-10A were used as the control, and circ_0000144 expression was detected in breast cancer cell lines(T47D, MCF-7, MDA-MB-231)by RT-qPCR. MCF-7 cells were used as the study object, and the transfected si-circ_0000144 group was set up as the experimental group(si-circ_0000144 group), the transfected si-NC group was set as the saline control group(si-NC group), and a blank control group(Control group)was set at the same time. The cells were cultured with conventional medium without any transfection operation. The abilities of cell proliferation, migration and invasion in breast cancer cells were detected by CCK-8, clone formation assay, flow cytometry, scratch assay and Transwell assay, and the protein expressions of CyclinD1, p21, Bax, Bcl-2, E-cadherin and N-cadherin were detected by Western blotting. Results The expression of circ_0000144 in breast cancer tissues was significantly elevated compared with that in normal tissues adjacent to the cancer(P<0.001), and was closely positively associated with TNM stage and lymph node metastasis(P=0.003, P=0.007). The expressions of circ_0000144 were up-regulated in breast cancer cell lines compared to normal breast epithelial cells MCF-10A(P<0.001). Compared with the Control group or si-NC group, the si-Circ_0000144 group showed reduced abilities of proliferate, migrate and invade(all P<0.001), elevated apoptosis rate(both P<0.001), decreased expression levels of CyclinD1, Bcl-2 and N-cadherin proteins(all P<0.001), and increased expression levels of p21, Bax and E-cadherin proteins(all P<0.001). Conclusion circ_0000144 is highly expressed in breast cancer tissues and cell lines. Down-regulation of circ_0000144 can hinder breast cancer cell proliferation, migration and invasion, and promote its apoptosis. circ_0000144 may become a molecular target for breast cancer treatment.

Key words: Breast cancer, circ_0000144, Proliferation, Apoptosis, Migration, Invasion

中图分类号: 

  • R730
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 dountries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2] 董相君, 李娟, 孔雪, 等. 环状 RNA hsa_circ_0008591 对乳腺癌细胞生物学行为的影响[J]. 山东大学学报(医学版), 2023, 61(2): 78-87. DONG Xiangjun, LI Juan, KONG Xue, et al. Effects of circular RNA hsa_circ_0008591 on tumor biological behavior of breast cancer cells[J]. Journal of Shangdong University(Health Sciences), 2023, 61(2): 78-87.
[3] Wang SY, Fu SQ, Chen Q, et al. Prognostic role of circular RNAs expression in bladder carcinoma: a meta-analysis[J]. Genet Test Mol Biomarkers, 2020, 24(11): 692-700.
[4] Mi LL, Lei LH, Yin XL, et al. Circ_0000144 functions as a miR-623 sponge to enhance gastric cancer progression via up-regulating GPRC5A[J]. Biosci Rep, 2020, 40(8): 1-12.
[5] Ji F, Lang C, Gao P, et al Knockdown of Circ_0000144 suppresses cell proliferation, migration and invasion in gastric cancer via sponging MiR-217[J]. J Microbiol Biotechnol, 2021, 31(6): 784-793.
[6] Yang B, Wang YW, Zhang K. Interactions between circRNA and protein in breast cancer[J]. Gene, 2024, 895: 148019. doi: 10.1016/j.gene.2023.148019.
[7] Kristensen LS, Jakobsen T, Hager H, et al. The emerging roles of circRNAs in cancer and oncology[J]. Nat Rev Clin Oncol, 2022, 19(3): 188-206.
[8] Zhang Y, Luo J, Yang W, et al. CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets[J]. Cell Death Dis, 2023, 14(6): 353. doi: 10.1038/s41419-023-05881-2.
[9] Li J, Zhang Q, Jiang D, et al. CircRNAs in lung cancer- role and clinical application[J]. Cancer Lett, 2022, 544: 215810. doi: 10.1016/j.canlet.2022.215810.
[10] Lu JC, Ma XM, Lin JH, et al. Circ_0020123 increases ZFX expression to facilitate non-small cell lung cancer progression by sponging miR-142-3p[J]. Cancer Manag Res, 2021, 13(5): 1687-1698.
[11] Fan YX, Shi HY, Hu YL, et al. Circ_0000144 facilitates the progression of thyroid cancer via the miR-217/AKT3 pathway[J]. J Gene Med, 2020, 22(12): e3269. doi:10.1002/jgm.3269.
[12] Wei JM, Wang JM, Gao XB, et al. Identification of differentially expressed circRNAs and a novel hsa_circ_0000144 that promote tumor growth in gastric cancer[J]. Cancer Cell Int, 2019, 19: 268. doi:10.1186/s12935-019-0975-y.
[13] Huang WP, Lu YY, Wang F, et al. Downregulation of circular RNA hsa_circ_0000144 inhibits bladder cancer progression via stimulating miR-217 and suppressing RUNX2 expression[J]. Gene, 2018, 678: 337-342. doi:10.1016/j.gene.2018.08.036.
[14] 韩森吉, 李媛, 李振, 等. IL-37 通过调控 LINC01554/miR-223-3p 轴抑制卵巢癌细胞增殖、迁移和侵袭[J]. 中国免疫学杂志, 2022, 38(13): 1607-1613. HAN Senji, LI Yuan, LI Zhen, et al. IL-37 inhibits proliferation, migration and invasion of ovarian cancer cells by regulating LINC01554/miR-223-3p axis[J]. Chinese Journal of Immunology, 2022, 38(13): 1607-1613.
[15] Benard O, Qian X, Liang HZ, et al. p21CIP1 promotes mammary cancer-initiating cells via activation of Wnt/TCF1/CyclinD1 signaling[J]. Mol Cancer Res, 2019, 17(7): 1571-1581.
[16] Dai XL, Guo X, Liu JJ, et al. Circular RNA circGRAMD1B inhibits gastric cancer progression by sponging miR-130a-3p and regulating PTEN and p21 expression[J]. Aging, 2019, 11(21): 9689-9708.
[17] Sun D, Wang G, Xiao C, et al. Hsa_circ_001988 attenuates GC progression in vitro and in vivo via sponging miR-197-3p[J]. J Cell Physiol, 2021, 236(1): 612-624.
[18] Bi JM, Liu HW, Dong W, et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence[J]. Mol Cancer, 2019, 18(1): 133. doi:10.1186/s12943-019-1060-9.
[19] Jia XB, Zhang Q, Xu L, et al. Lotus leaf flavonoids induce apoptosis of human lung cancer A549 cells through the ROS/p38 MAPK pathway[J]. Biol Res, 2021, 54(1): 7. doi:10.1186/s40659-021-00330-w.
[20] 魏闫若雪, 李梓绮, 刘春铖, 等. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报(医学版), 2024, 62(5): 89-94. WEI Yanruoxue, LI Ziqi, LIU Chuncheng, et al. Heterogeneous expression of SP1 in colorectal cancer and its clinical significance[J]. Journal of Shandong University(Health Sciences), 2024, 62(5): 89-94.
[21] Si AF, Wang LQ, Miao K, et al. MiR-219 regulates liver cancer stem cell expansion via E-cadherin pathway[J]. Cell Cycle, 2019, 18(24): 3550-3561.
[22] Jin JL, Liu H, Jin MS, et al. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis[J]. Aging(Albany NY), 2020, 12(12): 11623-11635.
[23] Pei C, Wang H, Shi C, et al. CircRNA hsa_circ_0013958 may contribute to the development of ovarian cancer by affecting epithelial-mesenchymal transition and apoptotic signaling pathways[J]. J Clin Lab Anal, 2020, 34(7): e23292. doi: 10.1002/jcla.23292.
[24] Chen WL, Jiang L, Wang JS, et al. Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition(EMT)in glioblastoma by regulating miR-628-5p/HMGB3 axis[J]. Eur Rev Med Pharmacol Sci, 2019, 23(24): 10874-10885.
[25] 张艳霞, 闫燕艳, 邓亮, 等. E-钙黏素和N-钙黏素在胃肠道间质瘤中的表达及其临床意义[J]. 山西大同大学学报(自然科学版), 2023, 39(1): 80-83. ZHANG Yanxia, YAN Yanyan, DENG Liang, et al. Expression and clinical significance of E-cadherin and N-cadherin in gastrointestinal stromal tumors[J]. Journal of Shanxi Datong University(Natural Science Edition), 2023, 39(1): 80-83.
[1] 张士宝 刘庆勇 阮喜云 陈杰 张建军 李宗武 杨广笑 王全颖. NT4-SAC-HA2-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19.
[2] 王晓磊 张海涛 张辉 郭成浩. 舒血宁注射液对高碘致培养血管内皮细胞损伤的保护作用[J]. 山东大学学报(医学版), 2209, 47(6): 38-.
[3] 鹿向东 杨伟 徐广明 曲元明. 脑膜瘤中PPAR-γ的表达及曲格列酮对脑膜瘤培养细胞生长的影响[J]. 山东大学学报(医学版), 2209, 47(6): 65-.
[4] 山东省医学会乳腺疾病多学科联合委员会. 乳腺癌多学科协作诊疗山东共识(2024年版)[J]. 山东大学学报 (医学版), 2025, 63(1): 10-16.
[5] 程跃启,王斐,于理想,郑超,余之刚. 曲妥珠单抗致HER2阳性乳腺癌患者心脏毒性的研究进展[J]. 山东大学学报 (医学版), 2025, 63(1): 17-24.
[6] 王敏,李习平,檀军,邱梅,侯泽宇,田莹,罗鸿莹,范超文,齐玲,俞琦,谢薇. 慢病毒载体介导Gag-Caspase-8诱导三阴性乳腺癌原代细胞凋亡及S期阻滞[J]. 山东大学学报 (医学版), 2025, 63(1): 25-34.
[7] 余之刚,郑超. 乳腺癌多学科诊疗的现状、挑战与创新模式[J]. 山东大学学报 (医学版), 2025, 63(1): 1-9.
[8] 刘向荣,张新胜,杨荩冉,杨雪艳,刘钊,刘英华. ω-6/ω-3多不饱和脂肪酸比值对不同肿瘤发病风险的系统综述和Meta分析[J]. 山东大学学报 (医学版), 2024, 62(8): 34-48.
[9] 杜学识,倪向敏,梁馨予,白倩,朱文艺,王建. 雌马酚对DN的保护作用及潜在靶点[J]. 山东大学学报 (医学版), 2024, 62(8): 49-58.
[10] 王静,刘晓菲,曾荣,许长娟,张锦涛,董亮. 基于机器学习算法鉴定哮喘的坏死性凋亡相关生物标志物[J]. 山东大学学报 (医学版), 2024, 62(7): 21-32.
[11] 张学宇,张学海,孙文青,刘晗,姜金波,刘寒,李远,陈晓梅. 重症新型冠状病毒肺炎伴侵袭性肺曲霉病及反复致命性消化道出血1例[J]. 山东大学学报 (医学版), 2024, 62(7): 56-61.
[12] 姜子晗,芦兴晨,孙露,赵蕙琛,左丹,马小莉,刘元涛,张玉超. NR4A1通过IκBα/NF-κB通路调控过氧化氢诱导人脐静脉内皮细胞凋亡的机制[J]. 山东大学学报 (医学版), 2024, 62(3): 11-19.
[13] 曹华琳,贾彦召,曲莉,尹昕. CircFAT1调节miR-296-3p/MAPRE1轴对鼻咽癌细胞增殖、凋亡和放疗敏感性的影响[J]. 山东大学学报 (医学版), 2023, 61(9): 38-46.
[14] 高玉杰,龙启福,胡英,许玉珍,王茹,永胜. 生物信息学鉴定低氧诱导小鼠肾脏线粒体损伤的Hub基因及其作用机制[J]. 山东大学学报 (医学版), 2023, 61(9): 57-68.
[15] 刘金波,刘凯文,向崇鑫,程雷. 西红花苷对椎间盘退变的保护作用[J]. 山东大学学报 (医学版), 2023, 61(9): 84-93.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!